Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Nephrology

John Weinberg, MD, COO, Veloxis Pharmaceuticals, describes the benefits of the Veloxis’ Envarsus, an orphan drug for the treatment of organ transplant rejection. Envarsus is a reformulation of tacrolimus, the current gold standard of treatment. The...
According to Reuters, the FDA has granted approval to Rockwell Medical Inc. for a drug used to treat iron loss in patients on dialysis. Anemia is commonly found in patients with chronic kidney disease who are on dialysis. Triferic replaces the 5 to 7 mg...
The American College of Physicians has released a new set of guidelines to reduce the risk of kidney stones, CBS News reports. Roughly 20 percent of Americans will develop a kidney stone at least once in their life, with the risk for additional cases...